| |
n=19 |
Proportion |
| Latency Period |
|
|
| >20 years |
3 |
16% |
| 10-20 years |
11 |
58% |
| 5-9 years |
5 |
26% |
| 1-4 years |
0 |
0% |
| Site |
|
|
| Neck |
8 |
42% |
| Oropharynx / Oral cavity |
4 |
21% |
| Nasopharynx |
3 |
16% |
| Nasal Cavity |
2 |
11% |
| Maxilla |
1 |
5.3% |
| Mandible |
1 |
5.3% |
| Histology |
|
|
| Undifferentiated |
6 |
32% |
| Osteosarcoma |
4 |
21% |
| Rhabdomyosarcoma |
4 |
21% |
| Pleomorphic sarcoma |
2 |
11% |
| Angiosarcoma |
1 |
5.3% |
| Leiomyosarcoma |
1 |
5.3% |
| Malignant fibrohistiosarcoma |
1 |
5.3% |
|
